Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VICTOR A HERNANDEZ-ALONSO

Allopathic & Osteopathic Physicians General Practice

NPI
1144496555
CMS profile
851232
Location
SAN JUAN, PR

General Payments · PY2018–2024

$3,859.46

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$589.82

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $589.82 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $458.12 8
Boehringer Ingelheim Pharmaceuticals, Inc. $81.70 3
Exact Sciences Corporation $50.00 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,947.29 16
PY2019 $313.03 5
PY2021 $269.58 8
PY2022 $481.46 14
PY2023 $258.28 7
PY2024 $589.82 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $20.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104714165 CMS
AstraZeneca Pharmaceuticals LP $11.46 03/11/2024 Food and Beverage Undisputed 01/23/2026 1104251837 CMS
AstraZeneca Pharmaceuticals LP $125.00 03/13/2024 Food and Beverage Undisputed 01/23/2026 1105564448 CMS
AstraZeneca Pharmaceuticals LP $107.95 05/22/2024 Food and Beverage Undisputed 01/23/2026 1105808884 CMS
AstraZeneca Pharmaceuticals LP $25.00 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104567098 CMS
AstraZeneca Pharmaceuticals LP $118.71 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105703842 CMS
AstraZeneca Pharmaceuticals LP $25.00 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105600405 CMS
AstraZeneca Pharmaceuticals LP $25.00 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105353093 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.70 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117890583 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117890579 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117890581 CMS
Exact Sciences Corporation $25.00 08/12/2024 Food and Beverage Undisputed 01/23/2026 1114700608 CMS
Exact Sciences Corporation $25.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1114700614 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.